admera_health_final_logo_transparent_final.jpg
Admera Health Expands Asian Footprint with Three Strategic Partnerships
12 sept. 2017 11h05 HE | Admera Health, LLC
SOUTH PLAINFIELD, N.J., Sept. 12, 2017 (GLOBE NEWSWIRE) -- Today, Admera Health announced agreements expanding Admera’s portfolio of molecular diagnostics to Asia, including but not limited to...
admera_health_final_logo_transparent_final.jpg
Columbia University Medical Center’s Center for Biomedical Informatics Collaborates with Admera Health in a Clinical Study, Evaluating Pharmacogenetics in Psychiatric Medications
25 juil. 2017 19h00 HE | Admera Health, LLC
SOUTH PLAINFIELD, N.J., July 25, 2017 (GLOBE NEWSWIRE) -- Admera Health, an advanced molecular diagnostic laboratory, has been selected by Columbia University Medical Center’s Center for Biomedical...
admera_health_final_logo_transparent_final.jpg
Admera Health Partners with Helix to Launch Genetic Tests to Assess the Risk of Inherited High Cholesterol, Sudden Cardiac Death, and Inherited Diabetes
24 juil. 2017 07h45 HE | Admera Health, LLC
SOUTH PLAINFIELD, N.J., July 24, 2017 (GLOBE NEWSWIRE) -- Admera Health, a molecular diagnostics company developing comprehensive genetic tests for the risk assessment and early diagnosis of...
admera_health_final_logo_transparent_final.jpg
Health in Code’s Novel Work Published In JACC, Helps Increase Sensitivity Detection for Admera Health’s CardioGxOne™ Test Regarding Patients with High-Risk Dilated and Arrhythmogenic Cardiomyopathies
03 mai 2017 09h13 HE | Admera Health, LLC
A CORUÑA, Spain and SOUTH PLAINFIELD, N.J., May 03, 2017 (GLOBE NEWSWIRE) -- Today, Health in Code (HiC), (www.healthincode.com) a thought leader in the genetic cardiovascular field announced...